Study on Guselkumab Therapy's Impact on NAFLD in PsA Patients
The study investigates the effects of Guselkumab on disease severity in PsA patients with NAFLD.
Indication
Clinical and regulatory intelligence for Psoriatic Arthritis with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.